Precipio (PRPO) Competitors $5.91 -0.09 (-1.50%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends PRPO vs. OPTX, DAIO, BNGO, ASTC, TLIS, TBIO, SPEC, THMO, OLITW, and PRENWShould you be buying Precipio stock or one of its competitors? The main competitors of Precipio include Syntec Optics (OPTX), Data I/O (DAIO), Bionano Genomics (BNGO), Astrotech (ASTC), Talis Biomedical (TLIS), Telesis Bio (TBIO), Spectaire (SPEC), ThermoGenesis (THMO), OmniLit Acquisition (OLITW), and Prenetics Global (PRENW). These companies are all part of the "measuring and control equipment" industry. Precipio vs. Syntec Optics Data I/O Bionano Genomics Astrotech Talis Biomedical Telesis Bio Spectaire ThermoGenesis OmniLit Acquisition Prenetics Global Syntec Optics (NASDAQ:OPTX) and Precipio (NASDAQ:PRPO) are both small-cap business services companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, profitability, community ranking, institutional ownership, media sentiment, analyst recommendations, valuation and risk. Does the MarketBeat Community believe in OPTX or PRPO? Precipio received 272 more outperform votes than Syntec Optics when rated by MarketBeat users. CompanyUnderperformOutperformSyntec OpticsN/AN/APrecipioOutperform Votes27273.32% Underperform Votes9926.68% Does the media favor OPTX or PRPO? In the previous week, Precipio had 2 more articles in the media than Syntec Optics. MarketBeat recorded 2 mentions for Precipio and 0 mentions for Syntec Optics. Precipio's average media sentiment score of 1.19 beat Syntec Optics' score of 0.00 indicating that Precipio is being referred to more favorably in the news media. Company Overall Sentiment Syntec Optics Neutral Precipio Positive Which has more volatility & risk, OPTX or PRPO? Syntec Optics has a beta of -0.54, suggesting that its share price is 154% less volatile than the S&P 500. Comparatively, Precipio has a beta of 1.42, suggesting that its share price is 42% more volatile than the S&P 500. Do institutionals & insiders believe in OPTX or PRPO? 10.5% of Precipio shares are held by institutional investors. 0.2% of Syntec Optics shares are held by company insiders. Comparatively, 13.3% of Precipio shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Is OPTX or PRPO more profitable? Syntec Optics has a net margin of 0.21% compared to Precipio's net margin of -17.23%. Syntec Optics' return on equity of 0.50% beat Precipio's return on equity.Company Net Margins Return on Equity Return on Assets Syntec Optics0.21% 0.50% 0.23% Precipio -17.23%-34.01%-25.27% Which has stronger valuation and earnings, OPTX or PRPO? Syntec Optics has higher revenue and earnings than Precipio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSyntec Optics$29.44M1.09$1.98MN/AN/APrecipio$15.20M0.58-$5.85M-$1.83-3.23 SummarySyntec Optics and Precipio tied by winning 6 of the 12 factors compared between the two stocks. Ad StockEarnings9 hidden AI stocks set to thrive in Trump’s new eraAI ETFs are Booming, But These 9 AI Stocks are Better Plays By 2030, the AI industry is projected to be worth trillions of dollars (here’s how to tap into this new wealth)Get the Name of These AI Picks Now Get Precipio News Delivered to You Automatically Sign up to receive the latest news and ratings for PRPO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRPO vs. The Competition Export to ExcelMetricPrecipioAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.75M$5.46B$5.21B$8.85BDividend YieldN/A0.44%5.53%4.08%P/E Ratio-3.2312.3982.8815.55Price / Sales0.584.061,246.7687.28Price / CashN/A42.9440.9136.92Price / Book0.732.507.206.55Net Income-$5.85M$515,312.50$119.63M$226.22M7 Day Performance-4.56%1.55%2.12%3.77%1 Month Performance-10.46%-2.61%-2.43%4.64%1 Year Performance-15.88%-16.01%34.53%29.21% Precipio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRPOPrecipio1.1726 of 5 stars$5.91-1.5%N/A-15.9%$8.75M$15.20M-3.2360Positive NewsOPTXSyntec OpticsN/A$0.88-1.8%N/A-83.9%$32.36M$29.44M0.003Gap DownDAIOData I/O2.1241 of 5 stars$2.59-0.4%$4.00+54.4%-10.7%$23.93M$28.06M-13.68100BNGOBionano Genomics1.3483 of 5 stars$0.22+1.0%$1.50+577.8%-84.6%$22.57M$36.12M-0.09300ASTCAstrotechN/A$7.54-0.9%N/A-0.9%$12.82M$1.66M-1.0210TLISTalis BiomedicalN/A$1.69-1.4%N/A-75.8%$3.08M$2.13M-0.06260TBIOTelesis BioN/A$0.91+1.1%N/A-87.4%$1.62M$27.51M-0.03200SPECSpectaireN/A$0.06+22.2%N/A-96.6%$1.01MN/A0.008Gap UpTHMOThermoGenesisN/A$0.00+42.9%N/A-99.9%$8,000.00$9.44M0.0025OLITWOmniLit AcquisitionN/A$0.04flatN/A-46.8%$0.00N/A0.003Gap DownPRENWPrenetics GlobalN/A$0.01-22.5%N/AN/A$0.00$22.66M0.001Gap Down Related Companies and Tools Related Companies Syntec Optics Alternatives Data I/O Alternatives Bionano Genomics Alternatives Astrotech Alternatives Talis Biomedical Alternatives Telesis Bio Alternatives Spectaire Alternatives ThermoGenesis Alternatives OmniLit Acquisition Alternatives Prenetics Global Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PRPO) was last updated on 11/24/2024 by MarketBeat.com Staff From Our PartnersNew post-election stock warning from Wall StreetIf you’re holding U.S. stocks, it may be time to brace for impact. The S&P 500 crossed 6,000 for the first ...Chaikin Analytics | SponsoredPopular Stocks at Risk Under Trump—Are You Holding These?The Stocks Most At-Risk from Trump’s Victory Free e-book reveals sectors – and stocks within them – likely ...StockEarnings | SponsoredDonald Trump can’t save you from this crisisElon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force...Wide Moat Research | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | Sponsored[Urgent] Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it a...Paradigm Press | Sponsored📉 Warning: Market Crash Predicted - Secure Your SavingsThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredShocking footage from Bill Gates’ $100,000,000,000 AI BetIf you missed out on Nvidia, watch this video I just made.Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Precipio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Precipio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PRPO Stock Alerts